Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff

1
Neurodegenerative Diseases Market to
2018 

• Bharat Book Bureau

2
Summary

• Neurodegenerative Diseases Market to 2018 -
  New product entries in both niche and broader
  Parkinsons disease treatment will boost market
  despite patent cliff. A highly dynamic market
  scenario is expected in Neurodegenerative
  diseases in the next few years, with a number of
  patent expiries and anticipated new drug
  approvals. The market for Alzheimers disease has
  not seen any recent major breakthroughs, and is
  expected to experience a decline due to the
  patent expiry of several major products. The
  market for Parkinsons disease, on the other
  hand, is expected to experience growth due to the
  anticipated approval of expensive products such
  as Duodopa in the US, in spite of the fact that
  it will soon hit its own patent cliff.
  Additionally, the overall aging of populations
  the developed world is expected to increase the
  number of patients suffering from these diseases
  due to their relatively high prevalence in the
  elderly.

3
Continue

• Scope- The report analyzes treatment usage
  patterns, market characterization, pipeline
  analysis, and key MA and licensing deal trends
  in Alzheimers Disease (AD), Parkinsons Disease
  (PD), Amyotrophic Lateral Sclerosis (ALS) and
  Huntingtons Disease (HD). - The current
  therapeutic environment in the treatment of AD,
  PD, HD and ALS across the top seven developed
  markets, including the US, Germany, France, the
  UK, Italy, Spain and Japan. - Market data on
  the geographical landscape and therapeutic
  landscape, including market size, annual cost of
  therapy, treatment usage patterns such as disease
  population and prescription populations.

4
Continue

• - Market forecasts for all four indications
  across the US, the top five countries in Europe
  (EU5) - Germany, France, the UK, Italy, and
  Spain- as well as Japan.- Key market drivers
  and barriers- The major deals that have taken
  place in the Neurodegenerative Diseases Market in
  recent years. Coverage includes Mergers and
  Acquisitions (MAs) as well as co-development and
  licensing agreements, which are segmented on the
  basis of geography and total value. A concomitant
  analysis of the licensing deal values for
  products by molecule types and is also provided.

5
Continue

• Reasons to buyThe report will assist
  business development and marketing executives to
  strategize their product launches, by allowing
  them to - - Understand the competitive
  environment for Neurodegenerative Diseases-
  Understand the clinical and commercial impact of
  major patent expiries in the neurodegenerative
  diseases markets- Assess the potential clinical
  and commercial impact of current late-stage
  pipeline molecules on the neurodegenerative
  diseases market in the forecast period- Grasp
  the unmet need which exists in the
  neurodegenerative diseases Market- Exploit
  in-licensing and out-licensing opportunities by
  identifying products that might fill their
  portfolio gaps

6
Table of Contents

• 1 Table of Contents 61.1 List of Tables
  91.2 List of Figures 112 Neurodegenerative
  Diseases Market to 2018 Introduction 133
  Neurodegenerative Diseases Market to 2018 Global
  Market Overview 143.1 Revenue 143.2 Treatment
  Usage Pattern 163.3 Distribution by Market
  173.4 Drivers and Restraints of the
  Neurodegenerative Diseases Market 183.4.1
  Drivers 183.4.2 Restraints 184 Therapeutic
  Landscape 194.1 Market for Alzheimers Disease
  194.1.1 Introduction 194.1.2 Revenue and
  Forecasts 21

7
Continue

• 4.1.3 Treatment Usage Pattern 234.1.4
  Geographical Landscape 244.1.5 Drivers and
  Restraints for the Alzheimers Disease Market
  464.2 Market for Parkinsons Disease 474.2.1
  Introduction 474.2.2 Revenue and Forecasts
  494.2.3 Treatment Usage Pattern 504.2.4
  Geographical Landscape 514.2.5 Drivers and
  Restraints for the Parkinsons Disease Market
  734.3 Market for Amyotrophic Lateral Sclerosis
  744.3.1 Introduction 744.3.2 Revenue and
  Forecasts 764.3.3 Treatment Usage Pattern
  774.3.4 Geographical Landscape 784.3.5 Drivers
  and Restraints for the Amyotrophic Lateral
  Sclerosis Market 100

8
For More Information You Can Visit-

• http//www.bharatbook.com/market-research-rep
  orts/healthcare-market-research-report/neurodegene
  rative-diseases-market-to-2018-new-product-entries
  -in-both-niche-and-broader-parkinsonE28099s-dis
  ease-treatment-will-boost-market-despite-patent-cl
  iff.html
• Or visit us at
• Bharat Book
  Bureau Phone
  91 22 27810772, 27810773
  Toll Free No for USA/Canada
  1-866-279-8368
  Fax [phone]
  E-mail info_at_bharatbook.com
  Website www.bharatbook.com
  Twitter
  https//twitter.com/BharatBook
  Blog http//www.bharatbook.com/mar
  ket-reports-blog/